175 related articles for article (PubMed ID: 33541472)
1. Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study.
Henderson A; Kinnear D; Fleming M; Stanley B; Greenlaw N; Young-Southward G; Pell JP; Cooper SA
Br J Psychiatry; 2021 Jan; 218(1):58-62. PubMed ID: 33541472
[TBL] [Abstract][Full Text] [Related]
2. Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study.
Henderson A; Mcskimming P; Kinnear D; McCowan C; McIntosh A; Allan L; Cooper SA
BMJ Open; 2020 Sep; 10(9):e036862. PubMed ID: 32912946
[TBL] [Abstract][Full Text] [Related]
3. Rates and causes of mortality among children and young people with and without intellectual disabilities in Scotland: a record linkage cohort study of 796 190 school children.
Smith GS; Fleming M; Kinnear D; Henderson A; Pell JP; Melville C; Cooper SA
BMJ Open; 2020 Aug; 10(8):e034077. PubMed ID: 32773385
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
Deb S; Unwin G; Deb T
J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and patterns of anti-epileptic medication prescribing in the treatment of epilepsy in older adults with intellectual disabilities.
O'Dwyer M; Peklar J; Mulryan N; McCallion P; McCarron M; Henman MC
J Intellect Disabil Res; 2018 Mar; 62(3):245-261. PubMed ID: 29314463
[TBL] [Abstract][Full Text] [Related]
6. Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
Sheehan R; Hassiotis A; Walters K; Osborn D; Strydom A; Horsfall L
BMJ; 2015 Sep; 351():h4326. PubMed ID: 26330451
[TBL] [Abstract][Full Text] [Related]
7. Psychotropic prescribing for persons with intellectual disabilities and other psychiatric disorders.
Edelsohn GA; Schuster JM; Castelnovo K; Terhorst L; Parthasarathy M
Psychiatr Serv; 2014 Feb; 65(2):201-7. PubMed ID: 24233105
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic Use With and Without Comorbid Psychiatric Diagnosis Among Adults with Intellectual and Developmental Disabilities.
Lunsky Y; Khuu W; Tadrous M; Vigod S; Cobigo V; Gomes T
Can J Psychiatry; 2018 Jun; 63(6):361-369. PubMed ID: 28830241
[TBL] [Abstract][Full Text] [Related]
9. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Children Prescribed Antipsychotics: Analysis of Routinely Collected Data.
Brophy S; Kennedy J; Fernandez-Gutierrez F; John A; Potter R; Linehan C; Kerr M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):180-191. PubMed ID: 29486137
[TBL] [Abstract][Full Text] [Related]
11. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
Sultan RS; Correll CU; Schoenbaum M; King M; Walkup JT; Olfson M
J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):158-165. PubMed ID: 29376743
[TBL] [Abstract][Full Text] [Related]
12. Experiences with Patient Refusal of Off-Label Prescribing of Psychotropic Medications to Children and Adolescents in Japan.
Tsujii N; Saito T; Izumoto Y; Usami M; Okada T; Negoro H; Iida J
J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):642-5. PubMed ID: 26103533
[TBL] [Abstract][Full Text] [Related]
13. Cohort profile: Scotland's record-linkage e-cohorts of people with intellectual disabilities, and autistic people (SCIDA).
Cooper SA; Henderson A; Kinnear D; Mackay D; Fleming M; Smith GS; Hughes-McCormack LA; Rydzewska E; Dunn K; Pell JP; Melville C
BMJ Open; 2022 May; 12(5):e057230. PubMed ID: 35568493
[TBL] [Abstract][Full Text] [Related]
14. Antidepressant prescribing for adult people with an intellectual disability living in England.
Branford D; Shankar R
Br J Psychiatry; 2022 Aug; 221(2):488-493. PubMed ID: 35249557
[TBL] [Abstract][Full Text] [Related]
15. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
Inoue Y; Okumura Y; Fujita J
Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic Use Among Youths With Intellectual and Developmental Disabilities.
McLaren JL; Lichtenstein JD; Metcalfe JD; Charlot LR; Drake RE; Beasley JB
Psychiatr Serv; 2021 Sep; 72(9):988-997. PubMed ID: 33882691
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Young People With Antipsychotic Medications in the United States.
Olfson M; King M; Schoenbaum M
JAMA Psychiatry; 2015 Sep; 72(9):867-74. PubMed ID: 26132724
[TBL] [Abstract][Full Text] [Related]
18. [Antidepressant and antipsychotic drug prescribing in Lombardy].
Percudani M; Barbui C; Fortino I; Tansella M; Petrovich L
Epidemiol Psichiatr Soc; 2006; 15(1):59-70. PubMed ID: 16584104
[TBL] [Abstract][Full Text] [Related]
19. Rates, causes and predictors of all-cause and avoidable mortality in 163 686 children and young people with and without intellectual disabilities: a record linkage national cohort study.
Hughes-McCormack LA; Rydzewska E; Cooper SA; Fleming M; Mackay D; Dunn K; Ward L; Sosenko F; Barlow F; Miller J; Symonds JD; Jani BD; Truesdale M; Cairns D; Pell J; Henderson A; Melville C
BMJ Open; 2022 Sep; 12(9):e061636. PubMed ID: 36113944
[TBL] [Abstract][Full Text] [Related]
20. Use of psychotropic medications in adults with intellectual disability: A systematic review and meta-analysis.
Song M; Rubin BS; Ha JW; Ware RS; Doan TN; Harley D
Aust N Z J Psychiatry; 2023 May; 57(5):661-674. PubMed ID: 36700564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
